Skip to content

The medtech industry is positioned for continued growth as the aging world population faces many unmet medical needs. According to market analysts, industry revenue is predicted to grow to nearly $600 billion in 2024, with the cardiovascular, orthopedic, neurological, urological, and diabetes sectors driving that growth.

Several trends are shaping the medtech industry, presenting opportunities and challenges for both early stage and established medtech companies. From raising capital to building a strategic intellectual property (IP) portfolio to the growing influence of artificial intelligence (AI), below are four megatrends impacting medtech.

Click here to read the full article, published by Medical Design & Outsourcing March 28, 2024.

Print:
Email this postTweet this postLike this postShare this post on LinkedIn
Photo of David J. Dykeman David J. Dykeman

David Dykeman, who serves as Co-Managing Shareholder of Greenberg Traurig’s Boston office and co-chairs the firm’s global Life Sciences & Medical Technology Group, is a registered patent attorney with more than 22 years of experience in patent and intellectual property law. David’s practice

David Dykeman, who serves as Co-Managing Shareholder of Greenberg Traurig’s Boston office and co-chairs the firm’s global Life Sciences & Medical Technology Group, is a registered patent attorney with more than 22 years of experience in patent and intellectual property law. David’s practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology.

David provides strategic patent portfolio development and intellectual property advice for clients including major research institutions, multi-national corporations, and start-up companies. He also performs patent due diligence to assess patent portfolios for venture capital investment, mergers and acquisitions, and licensing opportunities.

An author of over 50 articles and a speaker at over 45 conferences on intellectual property law, David is the founding co-chair of the ABA’s Medical Devices Committee. He was honored as one of Boston’s “40 Under 40” innovative business leaders by the Boston Business Journal and was named to the “40 Medtech Innovators Under 40” list by Medical Device & Diagnostic Industry (MD+DI) Magazine. David has also been named one of the top 250 Patent and Technology Licensing Practitioners in the world by Intellectual Asset Management (IAM) Magazine, an “IP Star” by Managing IP magazine, a “Life Science Star” by LMG Life Sciences, and one of the World’s Leading IP Strategists in the IAM 300.

Photo of Roman Fayerberg Roman Fayerberg

Roman Fayerberg is a registered patent attorney with broad experience helping clients to strategically protect and leverage their innovations globally. Roman works with clients to develop and manage worldwide patent portfolios and counsels clients in regard to freedom to operate, patent landscape, and…

Roman Fayerberg is a registered patent attorney with broad experience helping clients to strategically protect and leverage their innovations globally. Roman works with clients to develop and manage worldwide patent portfolios and counsels clients in regard to freedom to operate, patent landscape, and patent infringement and validity matters. He also conducts and defends patent due diligence investigations in connection with venture capital investments, mergers and acquisitions, and licensing opportunities.

Roman has represented clients ranging from start-ups to global companies in a variety of technical areas, including medical devices, robotics, diagnostic and imaging systems, microfluidic devices, and biotechnology. He understands the legal goals of each of his clients and develops and executes patent strategies that meet such goals.